About this episode
James O'Hara sits down with Dr Dan Bristow (OB-GYN) to talk about hormones For High-quality labs:► http://sagebio.com/For information on the Gillett Health clinic, lab panels, and health coaching:► https://GillettHealth.comFollow Gillett Health for more content from James and Kyle► https://instagram.com/gilletthealth► https://www.tiktok.com/@gilletthealth► https://twitter.com/gilletthealth► https://www.facebook.com/gilletthealthFollow Kyle Gillett, MD► https://instagram.com/kylegillettmdFollow James O’Hara, NP► https://Instagram.com/jamesoharanpFor 10% off Gorilla Mind products, including SIGMA: Use code “GH10”► https://gorillamind.com/For discounts on high-quality supplements►https://www.thorne.com/u/GillettHealth►Compiled Source ListSystematic and Narrative Reviews 1. Gut microbial β‑glucuronidase: a vital regulator in female estrogen metabolism and gynecologic cancersPMCID: PMC10416750 • Year: 2023 • Journal: International Journal of Molecular Sciences • Summary: Reviews role of β-glucuronidase in estrogen metabolism, breast cancer, endometriosis. 2. A New Paradigm in Gut Microbiota & Breast Cancer: β‑Glucuronidase as Therapeutic TargetDOI: 10.3390/pathogens12091086 • Year: 2023 • Journal: Pathogens • Summary: Emerging model proposing gmGUS as a direct target in estrogen-driven breast cancer. 3. Gut and oral microbiota in gynecologic cancers: mechanisms and therapeutic valueDOI: 10.1038/s41522-024-00577-7 • Year: 2024 • Journal: npj Biofilms and Microbiomes • Summary: Systematic review on microbiota’s role in ovarian, cervical, and breast cancers. Human Clinical or Case-Control Studies 4. Assessment of gut microbial β‑glucuronidase and β‑glucosidase activity in women with PCOSPMCID: PMC10366212 • Year: 2023 • Journal: Scientific Reports • Summary: Found significantly higher β-glucuronidase activity in PCOS patients. 5. Gut microbiota and
